These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7321047)

  • 1. Nickel is released from the ischemic myocardium and contracts coronary vessels by a Ca-dependent mechanism.
    Rubányi G; Ligeti L; Koller A
    J Mol Cell Cardiol; 1981 Nov; 13(11):1023-6. PubMed ID: 7321047
    [No Abstract]   [Full Text] [Related]  

  • 2. Nickel induces vasoconstriction in the isolated canine coronary artery by a tonic Ca2+-activation mechanism.
    Rubányi G; Kalabay L; Pataki T; Hajdú K
    Acta Physiol Acad Sci Hung; 1982; 59(2):155-9. PubMed ID: 7158370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of verapamil and phenoxybenzamine on nickel-induced coronary vasoconstriction in the anaesthetized dog.
    Koller A; Rubányi G; Ligeti L; Kovách AG
    Acta Physiol Acad Sci Hung; 1982; 59(3):287-90. PubMed ID: 7168347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of nickel ions in the pathogenesis of ischemic coronary vasoconstriction in the dog heart.
    Rubanyi G; Ligeti L; Koller A; Kovách AG
    J Mol Cell Cardiol; 1984 Jun; 16(6):533-46. PubMed ID: 6748088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the metabolic and energetic situation of ischemically stressed myocardium by verapamil after experimental coronary artery occlusion.
    Korb H; Hoeft A; Baller D; Schräder R; Wolpers HG; Hellige G
    Arzneimittelforschung; 1983; 33(11):1546-51. PubMed ID: 6686450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.
    Reimer KA; Lowe JE; Jennings RB
    Circulation; 1977 Apr; 55(4):581-7. PubMed ID: 837500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of calcium in the ischemic myocardium.
    Nayler WG
    Am J Pathol; 1981 Feb; 102(2):262-70. PubMed ID: 7008622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
    Godfraind T; Salomone S; Dessy C; Verhelst B; Dion R; Schoevaerts JC
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S34-41. PubMed ID: 1282611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of verapamil on the molecular characteristics of myocardial actomyosin in experimental ischemia].
    Kaĭfadzhian MA; Dzhanpoladian EG; Zaminian TS; Samvelian VM; Oganesian SS
    Biull Eksp Biol Med; 1986 Jan; 101(1):46-8. PubMed ID: 2417642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological differentiation between large and small coronary vessels.
    Tsukada T; Rubio R; Berne RM
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):255-67. PubMed ID: 6435555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of adrenergic receptors in Ni2+-induced coronary vasoconstriction.
    Rubányi G; Hajdú K; Pataki T; Bakos M
    Acta Physiol Acad Sci Hung; 1982; 59(2):161-7. PubMed ID: 6297240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of the kinetics of calcium washout from dog heart after ischaemia.
    Bui-Mong-Hung ; Appel M; De Mendonca M
    Cardiovasc Res; 1977 May; 11(3):260-3. PubMed ID: 872165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
    Ro YM; Markle DR; Goldstein SR; Speir E; Greene R; Steadman K; Aamodt R; Epstein SE; Patterson RE
    J Pharmacol Exp Ther; 1989 Feb; 248(2):654-60. PubMed ID: 2918474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of nickel-induced coronary vasoconstriction on the activity of the electrogenic Na+, K+-pump.
    Rubányi G; Bakos M; Hajdu K; Pataki T
    Acta Physiol Acad Sci Hung; 1982; 59(2):169-74. PubMed ID: 6297241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil and the myocardium.
    Nayler WG; Krikler D
    Postgrad Med J; 1974 Jul; 50(585):441-6. PubMed ID: 4619835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of verapamil and its combinations with glutamate and glycine on cardiodynamics, coronary flow and oxidative stress in isolated rat heart.
    Stojic I; Srejovic I; Zivkovic V; Jeremic N; Djuric M; Stevanovic A; Milanovic T; Djuric D; Jakovljevic V
    J Physiol Biochem; 2017 Feb; 73(1):141-153. PubMed ID: 27812957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic effects of various palliative drugs for coronary insufficiency].
    Deltour G
    Therapie; 1970; 25(2):293-322. PubMed ID: 4404034
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydrogen sulphide induces vasoconstriction of rat coronary artery via activation of Ca(2+) influx.
    Ping NN; Li S; Mi YN; Cao L; Cao YX
    Acta Physiol (Oxf); 2015 May; 214(1):88-96. PubMed ID: 25711469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis for the use of calcium antagonists in ischaemic heart disease.
    Nayler WG
    Drugs; 1992; 43 Suppl 1():21-7. PubMed ID: 1378784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.